{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T13:17:40Z","timestamp":1694006260050},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00120-014-3668-0","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T15:46:07Z","timestamp":1424187967000},"page":"202-209","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fokale Therapie des Prostatakarzinoms"],"prefix":"10.1007","volume":"54","author":[{"given":"V.","family":"Kasivisvanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.T.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kanthabalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Emberton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.U.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,18]]},"reference":[{"key":"3668_CR1","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1016\/S1470-2045(12)70388-1","volume":"13","author":"Ahmed","year":"2012","unstructured":"Ahmed HU, Arya M, Freeman A et al (2012) Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol 13:e509\u2013e517","journal-title":"Lancet Oncol"},{"key":"3668_CR2","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrclinonc.2014.44","volume":"11","author":"Ahmed","year":"2014","unstructured":"Ahmed HU, Berge V, Bottomley D et al (2014) Can we deliver randomized trials of focal therapy in prostate cancer? Nat Rev Clin Oncol 11:482\u2013491","journal-title":"Nat Rev Clin Oncol"},{"key":"3668_CR3","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/S1470-2045(12)70307-8","volume":"13","author":"Ahmed","year":"2012","unstructured":"Ahmed HU, Emberton M (2012) Focal HIFU for prostate cancer\u2014authors\u2018 reply. Lancet Oncol 13:e284","journal-title":"Lancet Oncol"},{"key":"3668_CR4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.juro.2014.03.033","volume":"192","author":"Barqawi","year":"2014","unstructured":"Barqawi AB, Stoimenova D, Krughoff K et al (2014) Targeted focal therapy for the management of organ confined prostate cancer. J Urol 192:749\u2013753","journal-title":"J Urol"},{"key":"3668_CR5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2011.314","volume":"105","author":"Catto","year":"2011","unstructured":"Catto JW, Robinson MC, Albertsen PC et al (2011) Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study. Br J Cancer 105:931\u2013937","journal-title":"Br J Cancer"},{"key":"3668_CR6","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.2004.10.062","volume":"22","author":"Cooperberg","year":"2004","unstructured":"Cooperberg MR, Lubeck DP, Meng MV et al (2004) The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22:2141\u20132149","journal-title":"J Clin Oncol"},{"key":"3668_CR7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.eururo.2012.05.072","volume":"62","author":"Dall","year":"2012","unstructured":"Dall\u2019era MA, Albertsen PC, Bangma C et al (2012) Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 62:976\u2013983","journal-title":"Eur Urol"},{"key":"3668_CR8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2214\/AJR.10.4263","volume":"194","author":"De","year":"2010","unstructured":"De Visschere PJ, De Meerleer GO, Futterer JJ et al (2010) Role of MRI in follow-up after focal therapy for prostate carcinoma. AJR Am J Roentgenol 194:1427\u20131433","journal-title":"AJR Am J Roentgenol"},{"key":"3668_CR9","doi-asserted-by":"crossref","unstructured":"Donaldson IA, Alonzi R, Barratt D et al (2014) Focal therapy: patients, interventions, and outcomes-a report from a consensus meeting. Eur Urol 2014 Sep 30. pii: S0302\u20132838(14)00955-5. doi: 10.1016\/j.eururo.2014.09.018 (Epub ahead of print)","DOI":"10.1016\/j.eururo.2014.09.018"},{"key":"3668_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/bju.12370","volume":"113","author":"Durand","year":"2014","unstructured":"Durand M, Barret E, Galiano M et al (2014) Focal cryoablation: a treatment option for unilateral low-risk prostate cancer. BJU Int 113:56\u201364","journal-title":"BJU Int"},{"key":"3668_CR11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2490-13-2","volume":"13","author":"Hale","year":"2013","unstructured":"Hale Z, Miyake M, Palacios DA et al (2013) Focal cryosurgical ablation of the prostate: a single institute\u2019s perspective. BMC Urol 13:2","journal-title":"BMC Urol"},{"key":"3668_CR12","doi-asserted-by":"crossref","first-page":"878319","DOI":"10.1155\/2014\/878319","volume":"2014","author":"Hirst","year":"2014","unstructured":"Hirst AM, Frame FM, Maitland NJ et al (2014) Low temperature plasma: a novel focal therapy for localized prostate cancer? Biomed Res Int 2014:878319","journal-title":"Biomed Res Int"},{"key":"3668_CR13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.juro.2012.10.009","volume":"189","author":"Kasivisvanathan","year":"2013","unstructured":"Kasivisvanathan V, Dufour R, Moore CM et al (2013) Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol 189:860\u2013866","journal-title":"J Urol"},{"key":"3668_CR14","first-page":"461","volume":"Oncol","author":"Kasivisvanathan","year":"2013","unstructured":"Kasivisvanathan V, Emberton M, Ahmed HU (2013) Focal therapy for prostate cancer: rationale and treatment opportunities. Clin Oncol (R Coll Radiol) 25:461\u2013473","journal-title":"Clin"},{"key":"3668_CR15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0022-5347(01)67600-6","volume":"153","author":"Kletscher","year":"1995","unstructured":"Kletscher BA, Qian J, Bostwick DG et al (1995) Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy. J Urol 153:904\u2013906","journal-title":"J Urol"},{"key":"3668_CR16","first-page":"55","volume":"16","author":"Lee","year":"2014","unstructured":"Lee T, Mendhiratta N, Sperling D et al (2014) Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience. Rev Urol 16:55\u201366","journal-title":"Rev Urol"},{"key":"3668_CR17","doi-asserted-by":"crossref","unstructured":"Li YH, Elshafei A, Agarwal G et al (2014) Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry. Prostate: 2014 Oct 4. doi: 10.1002\/pros.22881 (epub ahead of print)","DOI":"10.1002\/pros.22881"},{"key":"3668_CR18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2013.03.030","volume":"64","author":"Moore","year":"2013","unstructured":"Moore CM, Kasivisvanathan V, Eggener S et al (2013) Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64:544\u2013552","journal-title":"Eur Urol"},{"key":"3668_CR19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.urolonc.2008.03.005","volume":"26","author":"Onik","year":"2008","unstructured":"Onik G, Barzell W (2008) Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 26:506\u2013510","journal-title":"Urol Oncol"},{"key":"3668_CR20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1148\/radiol.13121652","volume":"267","author":"Oto","year":"2013","unstructured":"Oto A, Sethi I, Karczmar G et al (2013) MR imaging-guided focal laser ablation for prostate cancer: phase I trial. Radiology 267:932\u2013940","journal-title":"Radiology"},{"key":"3668_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12022-003-0011-5","volume":"14","author":"Piersanti","year":"2003","unstructured":"Piersanti M, Ezzat S, Asa SL (2003) Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol 14:183\u2013191","journal-title":"Endocr Pathol"},{"key":"3668_CR22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","volume":"368","author":"Resnick","year":"2013","unstructured":"Resnick MJ, Koyama T, Fan KH et al (2013) Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 368:436\u2013445","journal-title":"N Engl J Med"},{"key":"3668_CR23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2013.09.045","volume":"66","author":"Singh","year":"2014","unstructured":"Singh PB, Anele C, Dalton E et al (2014) Prostate cancer tumour features on template prostate-mapping biopsies: implications for focal therapy. Eur Urol 66:12\u201319","journal-title":"Eur Urol"},{"key":"3668_CR24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2013.05.048","volume":"66","author":"Valerio","year":"2014","unstructured":"Valerio M, Ahmed HU, Emberton M et al (2014) The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol 66:732\u2013751","journal-title":"Eur Urol"},{"key":"3668_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cct.2014.07.006","volume":"39","author":"Valerio","year":"2014","unstructured":"Valerio M, Dickinson L, Ali A et al (2014) A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT). Contemp Clin Trials 39:57\u201365","journal-title":"Contemp Clin Trials"},{"key":"3668_CR26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/pcan.2014.33","volume":"17","author":"Valerio","year":"2014","unstructured":"Valerio M, Stricker PD, Ahmed HU et al (2014) Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis 17(4):343\u2013347","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3668_CR27","first-page":"756189","volume":"2014","author":"Van","year":"2014","unstructured":"Van Velthoven R, Aoun F, Limani K et al (2014) Primary zonal high intensity focused ultrasound for prostate cancer: results of a prospective phase IIa feasibility study. Prostate Cancer 2014:756189","journal-title":"Prostate Cancer"},{"key":"3668_CR28","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.juro.2006.08.007","volume":"176","author":"Villers","year":"2006","unstructured":"Villers A, Puech P, Mouton D et al (2006) Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 176:2432\u20132437","journal-title":"J Urol"},{"key":"3668_CR29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","volume":"367","author":"Wilt","year":"2012","unstructured":"Wilt TJ, Brawer MK, Jones KM et al (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367:203\u2013213","journal-title":"N Engl J Med"},{"key":"3668_CR30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-148-6-200803180-00209","volume":"148","author":"Wilt","year":"2008","unstructured":"Wilt TJ, Macdonald R, Rutks I et al (2008) Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148:435\u2013448","journal-title":"Ann Intern Med"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-014-3668-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-014-3668-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-014-3668-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:04:32Z","timestamp":1558609472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-014-3668-0"}},"subtitle":["Deutsche Version"],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3668"],"URL":"https:\/\/doi.org\/10.1007\/s00120-014-3668-0","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}